Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: VYNE Therapeutics(VYNE) the Revenue is 86 K (-57.43%);the EBIT is -3.816 M (+58.51%);the EPS is -4.19 (+58.46%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B57.43%
----
----
EBIT
-0.00B58.51%
----
----
EPS
-4.191258.46%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf